Original Article
Elevated soluble adhesion molecules in women with pre-eclampsia: Do cytokines like tumour necrosis factor-α and interleukin-1β cause endothelial activation?

https://doi.org/10.1016/S0301-2115(99)00042-1Get rights and content

Abstract

Objective: The purpose of the present study was to evaluate the clinical significance of tumour necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) for endothelial cell activation in pre-eclampsia. Therefore, we determined and compared the correlations between these cytokines and circulating adhesion molecules in the sera of pre-eclamptic pregnant women, normotensive pregnant women and nonpregnant women. Methods: The soluble adhesion molecules VCAM-1, ICAM-1, E-selectin, and P-selectin were determined in the serum of 38 pre-eclamptic pregnant women and 40 normotensive pregnant and nonpregnant controls using ELISA-techniques. We correlated these serum concentrations with the serum levels of TNF-α and IL-1β, respectively, also determined by ELISA. Results: Elevated serum levels of VCAM-1 and E-selectin could be detected in pre-eclamptic patients, with and without HELLP-syndrome. In contrast, no increased serum concentration of ICAM-1, P-selectin, TNF-α and IL-1β were found in these patients. While significant correlation between VCAM-1 and E-selectin could be determined (r=0.604; p<0.001) no unambiguous correlations, however, were found between TNF-α or between IL-1β and the examined adhesion molecules or the selectins. Conclusions: In contrast to in vitro investigations on cultured umbilical vein endothelium, our experimental results indicate that the cytokines TNF-α and IL-1β can not explain endothelial cell activation, and that their measurement in serum is not useful for the detection of pre-eclampsia.

Introduction

In pre-eclampsia endothelial dysfunction is of major significance [1]. Prerequisites for this situation can be an activation of endothelial cells by adhesion molecules accompanied by adhesion of leukocytes on the endothelial surface and subsequent transmigration of the leukocytes into the perivascular tissue [2], [3].

Increases in the serum concentrations of vascular adhesion molecule-1 (VCAM-1) [4], [5], [6], intercellular adhesion molecule-1 (ICAM-1) [5], [6], [7], [8], E-selectin [6], and P-selectin [9] have been detected as markers of an endothelial cell activation.

In vitro, cultured human endothelial cells can be stimulated to express VCAM-1, ICAM-1, and E-selectin as well as P-selectin by tumour necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) [10], [11].

In contrast to the above-mentioned in vitro findings, the role of cytokines, such as TNF-α and IL-1β for endothelial cell activation has not been clearly elucidated, especially since different results of these cytokines have been found in the sera of pre-eclamptic pregnant women [12], [13], [14], [15], [16], [17]. Several authors found elevated TNF-α serum levels in patients with pre-eclampsia [15], [17] or HELLP-syndrome [13] and concluded that this cytokine plays an active role in mediating the endothelial damage [13]. Vince et al. believe that endothelial dysfunction could arise for this excessive release of TNF-α into the circulation [17].

The objective of the present work was thus to comparatively investigate the correlations between TNF-α and IL-1β and circulating adhesion molecules in the sera of pre-eclamptic pregnant women and therefore, to evaluate their clinical significance for endothelial activation. These data were compared with serum levels of normotensive pregnant and nonpregnant women.

Section snippets

Patients

The study group contained 38 patients with pre-eclampsia, including 16 women with HELLP syndrome, while the control group contained 40 normotensive pregnant (n=20) and nonpregnant (n=20) women (Table 1a).

HELLP syndrome was defined as a combined appearance of hemolysis with decreased haptoglobin (<1.0 g/l), elevated liver enzymes (GOT ≥34 U/l and GPT ≥31 U/l), and thrombocytopenia below 100 000/μl [18], [19].

Pre-eclampsia was defined as a persisting elevated diastolic blood pressure ≥90 mmHg and

Results

The clinical findings reflecting the severity of the disease like thrombocytopenia, liver enzymes, and blood pressure are shown in Table 1b. Beside a significant decrease of platelets (p<0.001) in combination with elevated liver enzymes (p<0.001), patients with HELLP-syndrome demonstrated a significant increased blood pressure (p<0.01) when compared to the controls. Significantly decreased platelets (p<0.001) and elevated liver enzymes (p<0.001) could also be determined in pre-eclamptic

Discussion

Endothelial activation with adhesion of leukocytes in the course of inflammatory immunological processes has a particular pathogenetic significance in cases of pre-eclampsia. Increased serum levels of VCAM-1, ICAM-1, E-selectin, and P-selectin in pre-eclamptic patients have been mentioned in several reports [4], [5], [6], [7], [8], [9].

We also found significantly increased serum concentrations of VCAM-1 and E-selectin in patients with pre-eclampsia and HELLP syndrome in comparison to

Acknowledgements

The authors are grateful to Mrs. Maria Rieseweber and Mrs. Dagmar Wieland for valuable technical assistance.

References (26)

  • J.L. Gordon et al.

    Circulating endothelial adhesion molecules

  • J.M. Harlan et al.

    Proinflammatory role of leukocyte adhesion molecules

  • F. Lyall et al.

    The cell adhesion molecule, VCAM-1, is selectively elevated in serum in pre-eclampsia: does this indicate the mechanism of leukocyte activation?

    Br J Obstet Gynecol

    (1994)
  • Cited by (58)

    • Soluble selectins in preeclamptic and healthy normotensive pregnant women

      2013, Clinica e Investigacion en Ginecologia y Obstetricia
    • A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia

      2011, Cytokine
      Citation Excerpt :

      Database search and reference review returned 139 unique records of studies investigating the correlation between polymorphisms or concentrations of TNF-α/IL-6/IL-10 and PE. Some studies were excluded: the publication type was a review rather than a clinical study (n = 5) [17–21]; the study was published in a language other than English (n = 2) [22,23]; the study was not a case-control study (n = 22) [24–45]; it dealt with specimens other than maternal blood serum or reported cytokine excretion following exogenous stimulation (n = 33) [46–78]; cytokine concentrations were detected in periods other than the third trimester (n = 8) [79–86]; TNF-α-308G/A genotype frequencies were not clearly provided (n = 1) [87]; and concentration data were not provided as mean (±SD) (n = 25) [88–112]. Thus, only 43 studies were identified for meta-analysis [113–155].

    View all citing articles on Scopus
    View full text